Serveur d'exploration Covid (26 mars)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones

Identifieur interne : 000014 ( PascalFrancis/Checkpoint ); précédent : 000013; suivant : 000015

Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones

Auteurs : KRISHNAN SURESH KUMAR [Inde] ; Swastika Ganguly [Inde] ; Ravichandran Veerasamy [Malaisie] ; Erik De Clercq [Belgique]

Source :

RBID : Pascal:11-0128463

Descripteurs français

English descriptors

Abstract

A new series of 3-(benzylideneamino)-2-phenylquinazoline-4(3H)-ones were prepared through Schiff base formation of 3-amino-2-phenyl quinazoline-4(3)H-one with various substituted carbonyl compounds. Their chemical structures were elucidated by spectral studies. Cytotoxicity and antiviral activity were evaluated against herpes simplex virus-1 (KOS), herpes simplex virus-2 (G), vaccinia virus, vesicular stomatitis virus, herpes simplex virus-1 TK- KOS ACVr, para influenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4, Punta Toro virus, feline corona virus (FIPV), feline herpes virus, respiratory syncytial virus, influenza A H1N1 subtype, influenza A H3N2 subtype, and influenza B virus. Compound 2a showed better antiviral activity against the entire tested virus.


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

Pascal:11-0128463

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en" level="a">Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones</title>
<author>
<name sortKey="Krishnan Suresh Kumar" sort="Krishnan Suresh Kumar" uniqKey="Krishnan Suresh Kumar" last="Krishnan Suresh Kumar">KRISHNAN SURESH KUMAR</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Medicinal chemistry research Laboratory, KMCH College of Pharmacy</s1>
<s2>Coimbatore</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Coimbatore</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ganguly, Swastika" sort="Ganguly, Swastika" uniqKey="Ganguly S" first="Swastika" last="Ganguly">Swastika Ganguly</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Medicinal chemistry research Laboratory, Department of Pharmaceutical Sciences, Birla Institute of Technology</s1>
<s2>Ranchi</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Ranchi</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Veerasamy, Ravichandran" sort="Veerasamy, Ravichandran" uniqKey="Veerasamy R" first="Ravichandran" last="Veerasamy">Ravichandran Veerasamy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Faculty of Pharmacy, AIMST University</s1>
<s3>MYS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Malaisie</country>
<wicri:noRegion>Faculty of Pharmacy, AIMST University</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<affiliation wicri:level="4">
<inist:fA14 i1="04">
<s1>Rega Institute for Medical research, Katholieke Universiteit Leuven</s1>
<s2>3000 Leuven</s2>
<s3>BEL</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Belgique</country>
<placeName>
<region type="province" nuts="2">Province du Brabant flamand</region>
<settlement type="city">Louvain</settlement>
</placeName>
<orgName type="university">Katholieke Universiteit Leuven</orgName>
</affiliation>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">INIST</idno>
<idno type="inist">11-0128463</idno>
<date when="2010">2010</date>
<idno type="stanalyst">PASCAL 11-0128463 INIST</idno>
<idno type="RBID">Pascal:11-0128463</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">000015</idno>
<idno type="wicri:Area/PascalFrancis/Curation">000044</idno>
<idno type="wicri:Area/PascalFrancis/Checkpoint">000014</idno>
<idno type="wicri:explorRef" wicri:stream="PascalFrancis" wicri:step="Checkpoint">000014</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en" level="a">Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones</title>
<author>
<name sortKey="Krishnan Suresh Kumar" sort="Krishnan Suresh Kumar" uniqKey="Krishnan Suresh Kumar" last="Krishnan Suresh Kumar">KRISHNAN SURESH KUMAR</name>
<affiliation wicri:level="1">
<inist:fA14 i1="01">
<s1>Medicinal chemistry research Laboratory, KMCH College of Pharmacy</s1>
<s2>Coimbatore</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Coimbatore</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Ganguly, Swastika" sort="Ganguly, Swastika" uniqKey="Ganguly S" first="Swastika" last="Ganguly">Swastika Ganguly</name>
<affiliation wicri:level="1">
<inist:fA14 i1="02">
<s1>Medicinal chemistry research Laboratory, Department of Pharmaceutical Sciences, Birla Institute of Technology</s1>
<s2>Ranchi</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>Inde</country>
<wicri:noRegion>Ranchi</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="Veerasamy, Ravichandran" sort="Veerasamy, Ravichandran" uniqKey="Veerasamy R" first="Ravichandran" last="Veerasamy">Ravichandran Veerasamy</name>
<affiliation wicri:level="1">
<inist:fA14 i1="03">
<s1>Faculty of Pharmacy, AIMST University</s1>
<s3>MYS</s3>
<sZ>3 aut.</sZ>
</inist:fA14>
<country>Malaisie</country>
<wicri:noRegion>Faculty of Pharmacy, AIMST University</wicri:noRegion>
</affiliation>
</author>
<author>
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
<affiliation wicri:level="4">
<inist:fA14 i1="04">
<s1>Rega Institute for Medical research, Katholieke Universiteit Leuven</s1>
<s2>3000 Leuven</s2>
<s3>BEL</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>Belgique</country>
<placeName>
<region type="province" nuts="2">Province du Brabant flamand</region>
<settlement type="city">Louvain</settlement>
</placeName>
<orgName type="university">Katholieke Universiteit Leuven</orgName>
</affiliation>
</author>
</analytic>
<series>
<title level="j" type="main">European journal of medicinal chemistry</title>
<title level="j" type="abbreviated">Eur. j. med. chem.</title>
<idno type="ISSN">0223-5234</idno>
<imprint>
<date when="2010">2010</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt>
<title level="j" type="main">European journal of medicinal chemistry</title>
<title level="j" type="abbreviated">Eur. j. med. chem.</title>
<idno type="ISSN">0223-5234</idno>
</seriesStmt>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Antiviral</term>
<term>Aromatic compound</term>
<term>Benzene derivatives</term>
<term>Bicyclic compound</term>
<term>Chemical synthesis</term>
<term>Feline infectious peritonitis virus</term>
<term>Herpesvirus hominis</term>
<term>In vitro</term>
<term>Nitrogen heterocycle</term>
<term>Non nucleoside compound</term>
<term>Quinazoline derivatives</term>
<term>Structure activity relation</term>
<term>Vaccinia virus</term>
<term>Vesicular stomatitis virus</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr">
<term>Synthèse chimique</term>
<term>Antiviral</term>
<term>Relation structure activité</term>
<term>Composé non nucléoside</term>
<term>Hétérocycle azote</term>
<term>Virus péritonite infectieuse féline</term>
<term>Herpesvirus hominis</term>
<term>Composé bicyclique</term>
<term>Virus vaccine</term>
<term>Virus stomatite vésiculeuse</term>
<term>Composé aromatique</term>
<term>Dérivé du benzène</term>
<term>In vitro</term>
<term>Dérivé de la quinazoline</term>
<term>Quinazolin-4-one dérivé</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">A new series of 3-(benzylideneamino)-2-phenylquinazoline-4(3H)-ones were prepared through Schiff base formation of 3-amino-2-phenyl quinazoline-4(3)H-one with various substituted carbonyl compounds. Their chemical structures were elucidated by spectral studies. Cytotoxicity and antiviral activity were evaluated against herpes simplex virus-1 (KOS), herpes simplex virus-2 (G), vaccinia virus, vesicular stomatitis virus, herpes simplex virus-1 TK- KOS ACVr, para influenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4, Punta Toro virus, feline corona virus (FIPV), feline herpes virus, respiratory syncytial virus, influenza A H1N1 subtype, influenza A H3N2 subtype, and influenza B virus. Compound 2a showed better antiviral activity against the entire tested virus.</div>
</front>
</TEI>
<inist>
<standard h6="B">
<pA>
<fA01 i1="01" i2="1">
<s0>0223-5234</s0>
</fA01>
<fA02 i1="01">
<s0>EJMCA5</s0>
</fA02>
<fA03 i2="1">
<s0>Eur. j. med. chem.</s0>
</fA03>
<fA05>
<s2>45</s2>
</fA05>
<fA06>
<s2>11</s2>
</fA06>
<fA08 i1="01" i2="1" l="ENG">
<s1>Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones</s1>
</fA08>
<fA11 i1="01" i2="1">
<s1>KRISHNAN SURESH KUMAR</s1>
</fA11>
<fA11 i1="02" i2="1">
<s1>GANGULY (Swastika)</s1>
</fA11>
<fA11 i1="03" i2="1">
<s1>VEERASAMY (Ravichandran)</s1>
</fA11>
<fA11 i1="04" i2="1">
<s1>DE CLERCQ (Erik)</s1>
</fA11>
<fA14 i1="01">
<s1>Medicinal chemistry research Laboratory, KMCH College of Pharmacy</s1>
<s2>Coimbatore</s2>
<s3>IND</s3>
<sZ>1 aut.</sZ>
</fA14>
<fA14 i1="02">
<s1>Medicinal chemistry research Laboratory, Department of Pharmaceutical Sciences, Birla Institute of Technology</s1>
<s2>Ranchi</s2>
<s3>IND</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03">
<s1>Faculty of Pharmacy, AIMST University</s1>
<s3>MYS</s3>
<sZ>3 aut.</sZ>
</fA14>
<fA14 i1="04">
<s1>Rega Institute for Medical research, Katholieke Universiteit Leuven</s1>
<s2>3000 Leuven</s2>
<s3>BEL</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA20>
<s1>5474-5479</s1>
</fA20>
<fA21>
<s1>2010</s1>
</fA21>
<fA23 i1="01">
<s0>ENG</s0>
</fA23>
<fA43 i1="01">
<s1>INIST</s1>
<s2>12640</s2>
<s5>354000193329240940</s5>
</fA43>
<fA44>
<s0>0000</s0>
<s1>© 2011 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45>
<s0>20 ref.</s0>
</fA45>
<fA47 i1="01" i2="1">
<s0>11-0128463</s0>
</fA47>
<fA60>
<s1>P</s1>
</fA60>
<fA61>
<s0>A</s0>
</fA61>
<fA64 i1="01" i2="1">
<s0>European journal of medicinal chemistry</s0>
</fA64>
<fA66 i1="01">
<s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG">
<s0>A new series of 3-(benzylideneamino)-2-phenylquinazoline-4(3H)-ones were prepared through Schiff base formation of 3-amino-2-phenyl quinazoline-4(3)H-one with various substituted carbonyl compounds. Their chemical structures were elucidated by spectral studies. Cytotoxicity and antiviral activity were evaluated against herpes simplex virus-1 (KOS), herpes simplex virus-2 (G), vaccinia virus, vesicular stomatitis virus, herpes simplex virus-1 TK- KOS ACVr, para influenza-3 virus, reovirus-1, Sindbis virus, Coxsackie virus B4, Punta Toro virus, feline corona virus (FIPV), feline herpes virus, respiratory syncytial virus, influenza A H1N1 subtype, influenza A H3N2 subtype, and influenza B virus. Compound 2a showed better antiviral activity against the entire tested virus.</s0>
</fC01>
<fC02 i1="01" i2="X">
<s0>002B02S05</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE">
<s0>Synthèse chimique</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG">
<s0>Chemical synthesis</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA">
<s0>Síntesis química</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE">
<s0>Antiviral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG">
<s0>Antiviral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA">
<s0>Antiviral</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE">
<s0>Relation structure activité</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG">
<s0>Structure activity relation</s0>
<s5>03</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA">
<s0>Relación estructura actividad</s0>
<s5>03</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE">
<s0>Composé non nucléoside</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG">
<s0>Non nucleoside compound</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA">
<s0>Compuesto no nucleósido</s0>
<s5>04</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE">
<s0>Hétérocycle azote</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG">
<s0>Nitrogen heterocycle</s0>
<s5>05</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA">
<s0>Heterociclo nitrógeno</s0>
<s5>05</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE">
<s0>Virus péritonite infectieuse féline</s0>
<s2>NW</s2>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG">
<s0>Feline infectious peritonitis virus</s0>
<s2>NW</s2>
<s5>06</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA">
<s0>Feline infectious peritonitis virus</s0>
<s2>NW</s2>
<s5>06</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE">
<s0>Herpesvirus hominis</s0>
<s2>NW</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG">
<s0>Herpesvirus hominis</s0>
<s2>NW</s2>
<s5>07</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA">
<s0>Herpesvirus hominis</s0>
<s2>NW</s2>
<s5>07</s5>
</fC03>
<fC03 i1="08" i2="X" l="FRE">
<s0>Composé bicyclique</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="ENG">
<s0>Bicyclic compound</s0>
<s5>08</s5>
</fC03>
<fC03 i1="08" i2="X" l="SPA">
<s0>Compuesto bicíclico</s0>
<s5>08</s5>
</fC03>
<fC03 i1="09" i2="X" l="FRE">
<s0>Virus vaccine</s0>
<s2>NW</s2>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="ENG">
<s0>Vaccinia virus</s0>
<s2>NW</s2>
<s5>09</s5>
</fC03>
<fC03 i1="09" i2="X" l="SPA">
<s0>Vaccinia virus</s0>
<s2>NW</s2>
<s5>09</s5>
</fC03>
<fC03 i1="10" i2="X" l="FRE">
<s0>Virus stomatite vésiculeuse</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="ENG">
<s0>Vesicular stomatitis virus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="10" i2="X" l="SPA">
<s0>Vesicular stomatitis virus</s0>
<s2>NW</s2>
<s5>10</s5>
</fC03>
<fC03 i1="11" i2="X" l="FRE">
<s0>Composé aromatique</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="ENG">
<s0>Aromatic compound</s0>
<s5>11</s5>
</fC03>
<fC03 i1="11" i2="X" l="SPA">
<s0>Compuesto aromático</s0>
<s5>11</s5>
</fC03>
<fC03 i1="12" i2="X" l="FRE">
<s0>Dérivé du benzène</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="ENG">
<s0>Benzene derivatives</s0>
<s5>12</s5>
</fC03>
<fC03 i1="12" i2="X" l="SPA">
<s0>Benceno derivado</s0>
<s5>12</s5>
</fC03>
<fC03 i1="13" i2="X" l="FRE">
<s0>In vitro</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="ENG">
<s0>In vitro</s0>
<s5>13</s5>
</fC03>
<fC03 i1="13" i2="X" l="SPA">
<s0>In vitro</s0>
<s5>13</s5>
</fC03>
<fC03 i1="14" i2="X" l="FRE">
<s0>Dérivé de la quinazoline</s0>
<s2>FR</s2>
<s5>33</s5>
</fC03>
<fC03 i1="14" i2="X" l="ENG">
<s0>Quinazoline derivatives</s0>
<s2>FR</s2>
<s5>33</s5>
</fC03>
<fC03 i1="15" i2="X" l="FRE">
<s0>Quinazolin-4-one dérivé</s0>
<s2>NK</s2>
<s4>INC</s4>
<s5>76</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE">
<s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="ENG">
<s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="01" i2="X" l="SPA">
<s0>Coronavirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="FRE">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="ENG">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="02" i2="X" l="SPA">
<s0>Coronaviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="FRE">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="ENG">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="03" i2="X" l="SPA">
<s0>Nidovirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="FRE">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="ENG">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="04" i2="X" l="SPA">
<s0>Virus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="FRE">
<s0>Alphaherpesvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="ENG">
<s0>Alphaherpesvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="05" i2="X" l="SPA">
<s0>Alphaherpesvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="FRE">
<s0>Herpesviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="ENG">
<s0>Herpesviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="06" i2="X" l="SPA">
<s0>Herpesviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="FRE">
<s0>Orthopoxvirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="ENG">
<s0>Orthopoxvirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="07" i2="X" l="SPA">
<s0>Orthopoxvirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="08" i2="X" l="FRE">
<s0>Chordopoxvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="08" i2="X" l="ENG">
<s0>Chordopoxvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="08" i2="X" l="SPA">
<s0>Chordopoxvirinae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="09" i2="X" l="FRE">
<s0>Poxviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="09" i2="X" l="ENG">
<s0>Poxviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="09" i2="X" l="SPA">
<s0>Poxviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="10" i2="X" l="FRE">
<s0>Vesiculovirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="10" i2="X" l="ENG">
<s0>Vesiculovirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="10" i2="X" l="SPA">
<s0>Vesiculovirus</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="11" i2="X" l="FRE">
<s0>Rhabdoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="11" i2="X" l="ENG">
<s0>Rhabdoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="11" i2="X" l="SPA">
<s0>Rhabdoviridae</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="12" i2="X" l="FRE">
<s0>Mononegavirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="12" i2="X" l="ENG">
<s0>Mononegavirales</s0>
<s2>NW</s2>
</fC07>
<fC07 i1="12" i2="X" l="SPA">
<s0>Mononegavirales</s0>
<s2>NW</s2>
</fC07>
<fN21>
<s1>087</s1>
</fN21>
</pA>
</standard>
</inist>
<affiliations>
<list>
<country>
<li>Belgique</li>
<li>Inde</li>
<li>Malaisie</li>
</country>
<region>
<li>Province du Brabant flamand</li>
</region>
<settlement>
<li>Louvain</li>
</settlement>
<orgName>
<li>Katholieke Universiteit Leuven</li>
</orgName>
</list>
<tree>
<country name="Inde">
<noRegion>
<name sortKey="Krishnan Suresh Kumar" sort="Krishnan Suresh Kumar" uniqKey="Krishnan Suresh Kumar" last="Krishnan Suresh Kumar">KRISHNAN SURESH KUMAR</name>
</noRegion>
<name sortKey="Ganguly, Swastika" sort="Ganguly, Swastika" uniqKey="Ganguly S" first="Swastika" last="Ganguly">Swastika Ganguly</name>
</country>
<country name="Malaisie">
<noRegion>
<name sortKey="Veerasamy, Ravichandran" sort="Veerasamy, Ravichandran" uniqKey="Veerasamy R" first="Ravichandran" last="Veerasamy">Ravichandran Veerasamy</name>
</noRegion>
</country>
<country name="Belgique">
<region name="Province du Brabant flamand">
<name sortKey="De Clercq, Erik" sort="De Clercq, Erik" uniqKey="De Clercq E" first="Erik" last="De Clercq">Erik De Clercq</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/CovidV2/Data/PascalFrancis/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000014 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Checkpoint/biblio.hfd -nk 000014 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    CovidV2
   |flux=    PascalFrancis
   |étape=   Checkpoint
   |type=    RBID
   |clé=     Pascal:11-0128463
   |texte=   Synthesis, antiviral activity and cytotoxicity evaluation of Schiff bases of some 2-phenyl quinazoline-4(3)H-ones
}}

Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Sat Mar 28 17:51:24 2020. Site generation: Sun Jan 31 15:35:48 2021